The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rucaparib API Market Research Report 2024
Synopsis
The global Rucaparib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rucaparib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rucaparib API.
Report Scope
The Rucaparib API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rucaparib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rucaparib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lepu Medical Technology
Teva API
Clovis Oncology
APExBIO Technology
Angle Bio Pharma
HUATENG PHARMA
Lonza
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Ovarian Cancer
Prostate Cancer
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rucaparib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Rucaparib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Rucaparib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Rucaparib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rucaparib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rucaparib API.
Report Scope
The Rucaparib API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rucaparib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rucaparib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lepu Medical Technology
Teva API
Clovis Oncology
APExBIO Technology
Angle Bio Pharma
HUATENG PHARMA
Lonza
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Ovarian Cancer
Prostate Cancer
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rucaparib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Rucaparib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Rucaparib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Rucaparib API Market Overview
1.1 Product Definition
1.2 Rucaparib API Segment by Type
1.2.1 Global Rucaparib API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Rucaparib API Segment by Application
1.3.1 Global Rucaparib API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Ovarian Cancer
1.3.3 Prostate Cancer
1.4 Global Market Growth Prospects
1.4.1 Global Rucaparib API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Rucaparib API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Rucaparib API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Rucaparib API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Rucaparib API Production Market Share by Manufacturers (2019-2024)
2.2 Global Rucaparib API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Rucaparib API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Rucaparib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Rucaparib API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Rucaparib API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Rucaparib API, Product Offered and Application
2.8 Global Key Manufacturers of Rucaparib API, Date of Enter into This Industry
2.9 Rucaparib API Market Competitive Situation and Trends
2.9.1 Rucaparib API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Rucaparib API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Rucaparib API Production by Region
3.1 Global Rucaparib API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Rucaparib API Production Value by Region (2019-2030)
3.2.1 Global Rucaparib API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Rucaparib API by Region (2025-2030)
3.3 Global Rucaparib API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Rucaparib API Production by Region (2019-2030)
3.4.1 Global Rucaparib API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Rucaparib API by Region (2025-2030)
3.5 Global Rucaparib API Market Price Analysis by Region (2019-2024)
3.6 Global Rucaparib API Production and Value, Year-over-Year Growth
3.6.1 North America Rucaparib API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Rucaparib API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Rucaparib API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Rucaparib API Production Value Estimates and Forecasts (2019-2030)
4 Rucaparib API Consumption by Region
4.1 Global Rucaparib API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Rucaparib API Consumption by Region (2019-2030)
4.2.1 Global Rucaparib API Consumption by Region (2019-2024)
4.2.2 Global Rucaparib API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Rucaparib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Rucaparib API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Rucaparib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Rucaparib API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Rucaparib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Rucaparib API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Rucaparib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Rucaparib API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Rucaparib API Production by Type (2019-2030)
5.1.1 Global Rucaparib API Production by Type (2019-2024)
5.1.2 Global Rucaparib API Production by Type (2025-2030)
5.1.3 Global Rucaparib API Production Market Share by Type (2019-2030)
5.2 Global Rucaparib API Production Value by Type (2019-2030)
5.2.1 Global Rucaparib API Production Value by Type (2019-2024)
5.2.2 Global Rucaparib API Production Value by Type (2025-2030)
5.2.3 Global Rucaparib API Production Value Market Share by Type (2019-2030)
5.3 Global Rucaparib API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Rucaparib API Production by Application (2019-2030)
6.1.1 Global Rucaparib API Production by Application (2019-2024)
6.1.2 Global Rucaparib API Production by Application (2025-2030)
6.1.3 Global Rucaparib API Production Market Share by Application (2019-2030)
6.2 Global Rucaparib API Production Value by Application (2019-2030)
6.2.1 Global Rucaparib API Production Value by Application (2019-2024)
6.2.2 Global Rucaparib API Production Value by Application (2025-2030)
6.2.3 Global Rucaparib API Production Value Market Share by Application (2019-2030)
6.3 Global Rucaparib API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Lepu Medical Technology
7.1.1 Lepu Medical Technology Rucaparib API Corporation Information
7.1.2 Lepu Medical Technology Rucaparib API Product Portfolio
7.1.3 Lepu Medical Technology Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Lepu Medical Technology Main Business and Markets Served
7.1.5 Lepu Medical Technology Recent Developments/Updates
7.2 Teva API
7.2.1 Teva API Rucaparib API Corporation Information
7.2.2 Teva API Rucaparib API Product Portfolio
7.2.3 Teva API Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Teva API Main Business and Markets Served
7.2.5 Teva API Recent Developments/Updates
7.3 Clovis Oncology
7.3.1 Clovis Oncology Rucaparib API Corporation Information
7.3.2 Clovis Oncology Rucaparib API Product Portfolio
7.3.3 Clovis Oncology Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Clovis Oncology Main Business and Markets Served
7.3.5 Clovis Oncology Recent Developments/Updates
7.4 APExBIO Technology
7.4.1 APExBIO Technology Rucaparib API Corporation Information
7.4.2 APExBIO Technology Rucaparib API Product Portfolio
7.4.3 APExBIO Technology Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 APExBIO Technology Main Business and Markets Served
7.4.5 APExBIO Technology Recent Developments/Updates
7.5 Angle Bio Pharma
7.5.1 Angle Bio Pharma Rucaparib API Corporation Information
7.5.2 Angle Bio Pharma Rucaparib API Product Portfolio
7.5.3 Angle Bio Pharma Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Angle Bio Pharma Main Business and Markets Served
7.5.5 Angle Bio Pharma Recent Developments/Updates
7.6 HUATENG PHARMA
7.6.1 HUATENG PHARMA Rucaparib API Corporation Information
7.6.2 HUATENG PHARMA Rucaparib API Product Portfolio
7.6.3 HUATENG PHARMA Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 HUATENG PHARMA Main Business and Markets Served
7.6.5 HUATENG PHARMA Recent Developments/Updates
7.7 Lonza
7.7.1 Lonza Rucaparib API Corporation Information
7.7.2 Lonza Rucaparib API Product Portfolio
7.7.3 Lonza Rucaparib API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Lonza Main Business and Markets Served
7.7.5 Lonza Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Rucaparib API Industry Chain Analysis
8.2 Rucaparib API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Rucaparib API Production Mode & Process
8.4 Rucaparib API Sales and Marketing
8.4.1 Rucaparib API Sales Channels
8.4.2 Rucaparib API Distributors
8.5 Rucaparib API Customers
9 Rucaparib API Market Dynamics
9.1 Rucaparib API Industry Trends
9.2 Rucaparib API Market Drivers
9.3 Rucaparib API Market Challenges
9.4 Rucaparib API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rucaparib API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Rucaparib API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Rucaparib API Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Rucaparib API Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Rucaparib API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Rucaparib API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Rucaparib API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Rucaparib API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rucaparib API as of 2023)
Table 10. Global Market Rucaparib API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Rucaparib API Production Sites and Area Served
Table 12. Manufacturers Rucaparib API Product Types
Table 13. Global Rucaparib API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Rucaparib API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Rucaparib API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Rucaparib API Production Value Market Share by Region (2019-2024)
Table 18. Global Rucaparib API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Rucaparib API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Rucaparib API Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global Rucaparib API Production (Tons) by Region (2019-2024)
Table 22. Global Rucaparib API Production Market Share by Region (2019-2024)
Table 23. Global Rucaparib API Production (Tons) Forecast by Region (2025-2030)
Table 24. Global Rucaparib API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Rucaparib API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Rucaparib API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Rucaparib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global Rucaparib API Consumption by Region (2019-2024) & (Tons)
Table 29. Global Rucaparib API Consumption Market Share by Region (2019-2024)
Table 30. Global Rucaparib API Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global Rucaparib API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Rucaparib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America Rucaparib API Consumption by Country (2019-2024) & (Tons)
Table 34. North America Rucaparib API Consumption by Country (2025-2030) & (Tons)
Table 35. Europe Rucaparib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe Rucaparib API Consumption by Country (2019-2024) & (Tons)
Table 37. Europe Rucaparib API Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific Rucaparib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific Rucaparib API Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific Rucaparib API Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa Rucaparib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa Rucaparib API Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa Rucaparib API Consumption by Country (2025-2030) & (Tons)
Table 44. Global Rucaparib API Production (Tons) by Type (2019-2024)
Table 45. Global Rucaparib API Production (Tons) by Type (2025-2030)
Table 46. Global Rucaparib API Production Market Share by Type (2019-2024)
Table 47. Global Rucaparib API Production Market Share by Type (2025-2030)
Table 48. Global Rucaparib API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Rucaparib API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Rucaparib API Production Value Share by Type (2019-2024)
Table 51. Global Rucaparib API Production Value Share by Type (2025-2030)
Table 52. Global Rucaparib API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Rucaparib API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Rucaparib API Production (Tons) by Application (2019-2024)
Table 55. Global Rucaparib API Production (Tons) by Application (2025-2030)
Table 56. Global Rucaparib API Production Market Share by Application (2019-2024)
Table 57. Global Rucaparib API Production Market Share by Application (2025-2030)
Table 58. Global Rucaparib API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Rucaparib API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Rucaparib API Production Value Share by Application (2019-2024)
Table 61. Global Rucaparib API Production Value Share by Application (2025-2030)
Table 62. Global Rucaparib API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Rucaparib API Price (US$/Ton) by Application (2025-2030)
Table 64. Lepu Medical Technology Rucaparib API Corporation Information
Table 65. Lepu Medical Technology Specification and Application
Table 66. Lepu Medical Technology Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Lepu Medical Technology Main Business and Markets Served
Table 68. Lepu Medical Technology Recent Developments/Updates
Table 69. Teva API Rucaparib API Corporation Information
Table 70. Teva API Specification and Application
Table 71. Teva API Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Teva API Main Business and Markets Served
Table 73. Teva API Recent Developments/Updates
Table 74. Clovis Oncology Rucaparib API Corporation Information
Table 75. Clovis Oncology Specification and Application
Table 76. Clovis Oncology Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Clovis Oncology Main Business and Markets Served
Table 78. Clovis Oncology Recent Developments/Updates
Table 79. APExBIO Technology Rucaparib API Corporation Information
Table 80. APExBIO Technology Specification and Application
Table 81. APExBIO Technology Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. APExBIO Technology Main Business and Markets Served
Table 83. APExBIO Technology Recent Developments/Updates
Table 84. Angle Bio Pharma Rucaparib API Corporation Information
Table 85. Angle Bio Pharma Specification and Application
Table 86. Angle Bio Pharma Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Angle Bio Pharma Main Business and Markets Served
Table 88. Angle Bio Pharma Recent Developments/Updates
Table 89. HUATENG PHARMA Rucaparib API Corporation Information
Table 90. HUATENG PHARMA Specification and Application
Table 91. HUATENG PHARMA Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. HUATENG PHARMA Main Business and Markets Served
Table 93. HUATENG PHARMA Recent Developments/Updates
Table 94. Lonza Rucaparib API Corporation Information
Table 95. Lonza Specification and Application
Table 96. Lonza Rucaparib API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Lonza Main Business and Markets Served
Table 98. Lonza Recent Developments/Updates
Table 99. Key Raw Materials Lists
Table 100. Raw Materials Key Suppliers Lists
Table 101. Rucaparib API Distributors List
Table 102. Rucaparib API Customers List
Table 103. Rucaparib API Market Trends
Table 104. Rucaparib API Market Drivers
Table 105. Rucaparib API Market Challenges
Table 106. Rucaparib API Market Restraints
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rucaparib API
Figure 2. Global Rucaparib API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Rucaparib API Market Share by Type: 2023 VS 2030
Figure 4. Purity ≥98% Product Picture
Figure 5. Purity ≥99% Product Picture
Figure 6. Global Rucaparib API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Rucaparib API Market Share by Application: 2023 VS 2030
Figure 8. Ovarian Cancer
Figure 9. Prostate Cancer
Figure 10. Global Rucaparib API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Rucaparib API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Rucaparib API Production Capacity (Tons) & (2019-2030)
Figure 13. Global Rucaparib API Production (Tons) & (2019-2030)
Figure 14. Global Rucaparib API Average Price (US$/Ton) & (2019-2030)
Figure 15. Rucaparib API Report Years Considered
Figure 16. Rucaparib API Production Share by Manufacturers in 2023
Figure 17. Rucaparib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Rucaparib API Revenue in 2023
Figure 19. Global Rucaparib API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Rucaparib API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Rucaparib API Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 22. Global Rucaparib API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Rucaparib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Rucaparib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Rucaparib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Japan Rucaparib API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Rucaparib API Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 28. Global Rucaparib API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 30. North America Rucaparib API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 32. U.S. Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 33. Europe Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 34. Europe Rucaparib API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 36. France Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 37. U.K. Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 38. Italy Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 39. Russia Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. Asia Pacific Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. Asia Pacific Rucaparib API Consumption Market Share by Regions (2019-2030)
Figure 42. China Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 43. Japan Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 44. South Korea Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 45. China Taiwan Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 46. Southeast Asia Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. India Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. Latin America, Middle East & Africa Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. Latin America, Middle East & Africa Rucaparib API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 51. Brazil Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 52. Turkey Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 53. GCC Countries Rucaparib API Consumption and Growth Rate (2019-2024) & (Tons)
Figure 54. Global Production Market Share of Rucaparib API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Rucaparib API by Type (2019-2030)
Figure 56. Global Rucaparib API Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Rucaparib API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Rucaparib API by Application (2019-2030)
Figure 59. Global Rucaparib API Price (US$/Ton) by Application (2019-2030)
Figure 60. Rucaparib API Value Chain
Figure 61. Rucaparib API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
